Type 2 diabetes is a common condition where the body either doesn’t use insulin effectively or doesn’t produce enough of it, ...

Managing diabetes has come a long way, thanks to advancements in treatments and technologies that make life easier and ...

This research marks a vital step towards innovative therapies, bringing new hope to millions affected by diabetes worldwide. ...

Learn more about the metabolic effects of liraglutide treatment in individuals with type 2 diabetes and obesity.

TennCare is federally required to cover GLP-1 drugs; of the $118M in the cost increase request, more than $76 million would ...

A genetic predisposition to having lower insulin production and less healthy fat distribution are major causes of early-onset type 2 diabetes in British Asian people. According to research, these ...